Insilico Medicine is a biotechnology company that focuses on artificial intelligence and machine learning to accelerate drug discovery and development. Founded in 2014, Insilico combines advanced computational methods with biology to identify new drug candidates and predict their potential efficacy and safety. The company's work includes the use of generative models for drug design, biomarker discovery, and the exploration of age-related diseases and other conditions.
Articles by others on the same topic
There are currently no matching articles.